Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EBIT Growth

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 21.2241.65-15.6018.7817.23

What is the latest EBIT Growth ratio of MANKIND PHARMA ?

The latest EBIT Growth ratio of MANKIND PHARMA is 21.22 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202521.22
Mar202441.65
Mar2023-15.60
Mar202218.78
Mar202117.23

How is EBIT Growth of MANKIND PHARMA Trending?

Years EBIT Growth % Change
Mar2025 21.22
-49.05
Mar2024 41.65
Positive
Mar2023 -15.6
Negative
Mar2022 18.78
9.00
Mar2021 17.23 -

Other Financial Ratios of MANKIND PHARMA


Compare EBIT Growth ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,035.9 Cr 0.3% -5.8% 13.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,115.0 Cr 3.5% -3.4% -5.8% Stock Analytics
DIVIS LABORATORIES ₹162,735.0 Cr 3.7% -10.2% 25.6% Stock Analytics
CIPLA ₹126,313.0 Cr 5.3% 6.1% -1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,592.0 Cr 1.4% 4.6% 7.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,095.0 Cr 3.9% 0% -9.9% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

0.3%

-5.8%

13.5%

SENSEX

-0%

-2.4%

1.2%


You may also like the below Video Courses